Biotest AG
BIESF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $1,151 | $1,095 | $1,018 | $1,148 |
| - Cash | $0 | $108 | $25 | $66 |
| + Debt | $0 | $597 | $0 | $624 |
| Enterprise Value | $1,151 | $1,584 | $993 | $1,706 |
| Revenue | $124 | $204 | $151 | $157 |
| % Growth | -39% | 35% | -3.9% | – |
| Gross Profit | $14 | $53 | $29 | $51 |
| % Margin | 11.4% | 26% | 19.4% | 32.6% |
| EBITDA | -$10 | $12 | $2 | $35 |
| % Margin | -7.7% | 5.8% | 1.5% | 22.2% |
| Net Income | -$21 | -$4 | -$9 | $10 |
| % Margin | -17.2% | -1.7% | -6.2% | 6.2% |
| EPS Diluted | -0.55 | -0.094 | -0.25 | 0.24 |
| % Growth | -485.1% | 62.4% | -204.2% | – |
| Operating Cash Flow | – | $38 | -$23 | $58 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $9 | -$23 | $58 |